Lee Cronin's "The Mummy" opened Friday to $5.1 million on 3,304 screens and is tracking to a $13 million weekend, placing third behind "Super Mario Galaxy Movie" ($30 million, weekend three, $350 million cume) and "Project Hail Mary" ($19.4 million, weekend five, $284 million). [1] [2] The number is neither a success nor a catastrophe. It is the number a name-above-title horror auteur can now deliver with a recognisable studio monster property and a $22 million net budget — which is its own quiet statement about where the industry's math has landed.

The credits tell the economics. New Line is the distributor; Jason Blum's Blumhouse and James Wan's Atomic Monster co-produced. The $22 million figure is net of the Irish Section 481 tax credit — gross production spend was closer to $28 million. [3] Jack Reynor and Laia Costa play Egyptologists whose excavation unearths, one recalls Boris Karloff from 1932 rather than Brendan Fraser from 1999, the wrapped body of a high priestess played by May Calamawy. No green-screen sandstorms. No Dwayne Johnson cameo. No Dark Universe. The bet: that "Evil Dead Rise" worked because Cronin directed it, and Universal's monsters can be rented profitably one at a time.

The audience decided the bet is paying. Cinemascore landed on B+, respectable for hard-R horror; Rotten Tomatoes shows a 46 percent critical score against a 76 percent audience score — not the era's widest split, but among the more instructive. [4] Critics complain of slowness in the first hour and a second act that mistakes restraint for mood. Audiences say the restraint is the point and Calamawy's performance anchors the film.

What the opening tells you about the horror economy in 2026 is that name-above-title is now a defensive posture. "Lee Cronin's The Mummy" signals no Dark Universe relaunch and no superhero leak. The possessive is an IP-contest admission: the brand cannot carry the title alone, so the author does half the work. [5]

Comparable openings form a tight cluster. "Evil Dead Rise" opened to $23.5 million in April 2023 on a $17 million budget and finished at $147 million worldwide. Cronin's "Mummy" will not hit that domestically, and it does not need to. International and streaming monetisation against a $22 million production spend can return the film profitable at $40 million global theatrical. [6]

The critical split is not a referendum on Cronin. It is a referendum on whether audiences still want horror to be slow. "Nosferatu" at Christmas answered yes. "Wolf Man" at January answered no. "Mummy" is somewhere in between: slower than Leigh Whannell, faster than Robert Eggers, with a lead performance from Calamawy that will be on actor-reel shortlists through the fall. The audience score will hold because the film earned it honestly, and the critical score will soften in the Monday takes. Neither will change the opening weekend number, which is the number that governs whether the sequel gets green-lit.

On that narrower question, the answer is: probably yes. Blumhouse's discipline and Wan's franchise sense will likely produce a "Frankenstein" greenlight for 2027 before the "Mummy" home-video window closes. Universal's monsters are not back. They are sharecropped to the auteurs who can afford to work small.

-- CAMILLE BEAUMONT, Los Angeles